The funnel effect after gastric sleeve surgery is a recognised complication in which the remaining stomach develops an uneven, tapered narrowing — typically at the mid-body — rather than maintaining a uniform tubular shape. Also described clinically as mid-gastric or incisural stenosis, this structural irregularity can impede the passage of food and liquid, causing symptoms ranging from nausea and dysphagia to persistent vomiting. In the UK, sleeve gastrectomy is performed under NICE guidance and BOMSS standards, making awareness of this complication essential for patients and clinicians alike to ensure prompt recognition and appropriate management.

What Is the Funnel Effect After Gastric Sleeve Surgery?

The funnel effect is a post-sleeve gastrectomy complication where the remaining stomach develops a tapered narrowing at the mid-body or angularis region, impeding food passage. It may overlap with sleeve torsion or stricture and is distinct from reflux complications.

Gastric sleeve surgery, formally known as sleeve gastrectomy, involves the surgical removal of approximately 75–80% of the stomach, leaving a narrow, tube-shaped pouch that restricts food intake and reduces hunger-related hormones such as ghrelin. While the procedure is highly effective for long-term weight management, a small proportion of patients may experience a complication known as the funnel effect — also referred to in clinical literature as mid-gastric stenosis, incisural stenosis, incisural kink, or sleeve torsion/twist.

The funnel effect describes a situation in which the remaining gastric sleeve develops an uneven or tapered narrowing, typically at the mid-body or angularis region of the stomach. Rather than maintaining a uniform tubular shape, the sleeve takes on a funnel-like configuration, with a wider upper portion and a significantly narrowed lower segment. This structural irregularity can impede the normal passage of food and liquid through the stomach and into the small intestine.

It is important to note that the boundary between a functional narrowing (such as a kink or twist) and a fixed stricture is not always clear-cut; these entities can overlap and may co-exist in the same patient. The distinction matters clinically, as it influences investigation and management choices.

Contributing factors are thought to include:

• Surgical technique, particularly staple line placement in close proximity to the incisura angularis

• Post-operative scarring or fibrosis along the staple line

• Twisting or torsion of the sleeve during healing

• Oedema or inflammation in the early post-operative period

The evidence base for these mechanisms is largely observational, and the relative contribution of each factor varies between patients and surgical approaches. The funnel effect is also distinct from — though may co-exist with — gastro-oesophageal reflux complications.

In the UK, sleeve gastrectomy is performed within NHS and independent bariatric services in accordance with NICE guidance (CG189; IPG432) and standards set by the British Obesity and Metabolic Surgery Society (BOMSS). Understanding the anatomical basis of this complication is essential for both patients and clinicians to ensure timely recognition and appropriate management.

Symptoms and Signs to Be Aware Of

Symptoms include dysphagia, persistent nausea, vomiting, regurgitation, and food sticking — none of which should be dismissed as normal recovery. Inability to tolerate fluids, dehydration, or vomiting blood requires urgent emergency assessment.

The symptoms associated with the funnel effect after gastric sleeve surgery can range from mild and intermittent to persistent and significantly disruptive to daily life. Because many post-operative symptoms overlap with expected early recovery experiences, patients and their clinical teams must remain vigilant about symptom patterns that persist or worsen — including those arising within the first few weeks after surgery, not only beyond the initial healing phase.

Common symptoms include:

• Dysphagia — difficulty swallowing solid foods, and in more severe cases, liquids

• Nausea and vomiting, particularly after eating, even small amounts

• Regurgitation of undigested food shortly after meals

• A sensation of food becoming stuck in the chest or upper abdomen

• Persistent heartburn or acid reflux, which may worsen over time

• Early satiety beyond what is expected following sleeve surgery

• Unintentional weight loss or failure to maintain adequate nutritional intake

In some patients, symptoms may develop gradually over weeks or months as post-operative fibrosis progresses. Others may notice an acute worsening following a period of relative stability. It is important to emphasise that vomiting after bariatric surgery should never be normalised — while some adjustment is expected in the early weeks, persistent or worsening vomiting warrants prompt clinical review at any stage.

Seek urgent medical attention — contact NHS 111, attend your nearest Emergency Department, or call 999 — if you experience any of the following:

• Inability to tolerate fluids for more than 24 hours

• Signs of dehydration (dark urine, dizziness, dry mouth, reduced urine output)

• Fever or feeling generally unwell with abdominal pain (which may indicate a leak or infection)

• Rapid or irregular heartbeat (tachycardia)

• Vomiting blood or passing black, tarry stools (haematemesis or melaena)

• Severe or rapidly worsening chest or abdominal pain

• Unintentional rapid weight loss

Early reporting of these symptoms is critical to preventing nutritional deficiencies, dehydration, and further complications. Patients should also contact their GP or bariatric team promptly for any symptoms that concern them, even if they do not meet the above urgent criteria.

Diagnosis and Assessment in UK Bariatric Services

Diagnosis involves clinical history, nutritional blood tests, and imaging — typically barium swallow or upper GI endoscopy — within a specialist bariatric MDT following NICE and BOMSS guidance. CT with oral contrast is used in complex cases to exclude other pathology.

Diagnosing the funnel effect requires a structured clinical assessment, typically carried out within a specialist bariatric or upper gastrointestinal surgical service. In the UK, most NHS bariatric centres follow pathways broadly aligned with NICE guidance on obesity (CG189), the interventional guidance for sleeve gastrectomy (NICE IPG432), and the standards set by the British Obesity and Metabolic Surgery Society (BOMSS), which recommend regular post-operative follow-up and clear escalation pathways for complications.

Initial assessment will usually involve a detailed clinical history, focusing on the onset, duration, and character of symptoms, alongside a review of dietary intake and weight trajectory. Blood tests are requested to assess for nutritional deficiencies and other abnormalities. In line with BOMSS biochemical monitoring guidance, a comprehensive panel is recommended, typically including:

• Full blood count (FBC), urea and electrolytes (U&Es), liver function tests (LFTs)

• Ferritin, vitamin B12, folate

• Vitamin D, calcium, and parathyroid hormone (PTH)

• Zinc, copper, and thiamine where clinically indicated (e.g., persistent vomiting)

• Inflammatory markers and dehydration indices where relevant

Imaging and endoscopic investigations are central to confirming the diagnosis. The choice of first-line investigation varies by centre and clinical presentation; both of the following are commonly used and are often complementary:

• Barium swallow (fluoroscopy) — a contrast study that allows real-time visualisation of the sleeve's shape and the passage of contrast material, and can clearly demonstrate a funnel-shaped narrowing or torsion

• Upper gastrointestinal endoscopy (OGD) — allows direct visualisation of the sleeve lumen, identification of strictures, mucosal abnormalities, or signs of reflux oesophagitis

• CT scan with oral contrast — may be used in complex cases or where other pathology (such as a leak or abscess) needs to be excluded

It is important that investigations are interpreted by clinicians experienced in bariatric anatomy, as post-sleeve appearances differ significantly from a normal stomach. A multidisciplinary team (MDT) approach — involving surgeons, dietitians, and gastroenterologists — is considered best practice in UK bariatric services when managing this type of complication, in line with the NHS England Service Specification for Severe and Complex Obesity.

Treatment Options and Clinical Management

Management follows a stepwise approach: dietary modification and PPIs for mild cases, endoscopic balloon dilation for stenosis, and conversion to Roux-en-Y gastric bypass when endotherapy fails. All decisions should be made within an MDT with shared patient decision-making.

The management of the funnel effect depends on the severity of symptoms, the degree of anatomical narrowing, and the patient's overall nutritional status. A stepwise approach is generally adopted, beginning with conservative measures and escalating to interventional or surgical options where necessary.

Conservative management is appropriate for mild cases and includes:

• Dietary modification — returning to a liquid or purée diet to reduce mechanical obstruction

• Nutritional support, including oral supplements or, in severe cases, nasogastric or parenteral feeding to correct deficiencies

• Proton pump inhibitors (PPIs) such as omeprazole to manage associated acid reflux; dosing should follow current BNF recommendations and the licensed indication as per the MHRA electronic Medicines Compendium (eMC) SmPC

Endoscopic balloon dilation is the most widely used interventional treatment for sleeve stenosis and funnel-related narrowing. Under sedation, a balloon catheter is passed through the endoscope and inflated at the site of narrowing to gently stretch the lumen. This procedure may need to be repeated on one or more occasions to achieve a satisfactory result. It carries a small risk of perforation and should only be performed in centres with appropriate surgical backup. In selected cases of refractory stenosis where repeated balloon dilation has failed, temporary fully covered self-expanding metal stents may be considered; however, this approach carries a risk of stent migration and requires specialist expertise, and the evidence base remains limited.

In cases where endoscopic treatment fails or where the anatomical distortion is severe, surgical revision may be considered. Options include:

• Conversion to Roux-en-Y gastric bypass, which bypasses the narrowed segment and is associated with good long-term outcomes; this is the most commonly performed surgical revision when endotherapy is unsuccessful

• Seromyotomy — a procedure to release fibrotic tissue along the staple line; this is infrequently performed and supported by limited evidence, and should only be considered in specialist centres

All treatment decisions should be made within an MDT setting, with clear documentation and patient involvement in shared decision-making, in line with NHS England's commissioning standards for bariatric surgery.

Patients and carers should be aware that suspected side effects from any medicine or medical device used during treatment can be reported to the MHRA via the Yellow Card scheme at yellowcard.mhra.gov.uk. Psychological support and dietetic input remain integral throughout the treatment process.

Experiencing these side effects? Our pharmacists can help you navigate them →

Long-Term Outlook and Follow-Up Care on the NHS

Most patients achieve good outcomes with timely treatment; NHS follow-up is recommended for at least two years in specialist care, then lifelong annual monitoring in primary care per BOMSS guidance. Lifelong nutritional supplementation and prompt reporting of recurrent symptoms remain essential.

For the majority of patients who receive timely diagnosis and appropriate treatment, the long-term outlook following the funnel effect is generally positive. Endoscopic dilation achieves symptomatic relief in a significant proportion of cases, and surgical revision — where required — can restore normal gastric function and allow patients to resume a nutritionally adequate diet. However, ongoing follow-up remains essential, as some patients may experience recurrence of narrowing or develop new complications over time.

Within the NHS, post-bariatric surgery follow-up is recommended for a minimum of two years in specialist care, in line with NICE CG189. After this period, care is typically handed over to primary care, with lifelong annual monitoring recommended in accordance with BOMSS guidance for GPs on post-bariatric monitoring and supplementation. Follow-up typically includes:

• Regular appointments with a bariatric dietitian to monitor dietary intake, eating behaviours, and nutritional status

• Annual blood tests to screen for micronutrient deficiencies, which are common after sleeve gastrectomy regardless of complications; the panel should follow BOMSS schedules (including FBC, ferritin, B12, folate, vitamin D, calcium, PTH, and others as clinically indicated)

• Access to psychological support where needed, particularly if complications have affected quality of life or relationship with food

• GP involvement for ongoing management of comorbidities such as type 2 diabetes or hypertension, which may change significantly following weight loss

Patients who have experienced the funnel effect should be counselled about the importance of lifelong nutritional supplementation. Core supplements typically include a bariatric-specific multivitamin and mineral preparation, vitamin D, calcium, and iron as appropriate. Vitamin B12 supplementation is particularly important after sleeve gastrectomy; depending on local protocol, this may include intramuscular (IM) hydroxocobalamin every three months, especially where oral absorption is uncertain. Patients should follow the specific regimen recommended by their bariatric team.

Patients should also be advised to report any recurrence of swallowing difficulties, vomiting, or unexplained weight changes promptly to their GP or bariatric team.

Not sure if this is normal? Chat with one of our pharmacists →

Regarding the relationship between surgical technique and the risk of developing the funnel effect: available evidence suggests that anatomical and technical factors — such as staple line placement relative to the incisura angularis — may influence risk, though robust comparative evidence is limited and outcomes vary between individuals and centres. Patients are encouraged to maintain open communication with their bariatric team and to engage fully with follow-up care to optimise their long-term health and wellbeing. Further information is available via the NHS website (nhs.uk) under weight loss surgery.

Frequently Asked Questions